Modular Medical, Inc. is a development stage company, which engages in the provision of insulin pump technology. The company is headquartered in San Diego, California and currently employs 54 full-time employees. The company went IPO on 2006-01-13. The firm is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The firm's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include two parts - one reusable, one disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; disposable portion removable at any time from an adhesive-backed retainer, which remains in place, and no external controller required, no charging and no battery replacement. MODD1 comes with a variety of methods for the patient to wear the pump. Options include a baseplate with adhesive for attaching to the body that has features for holding the pump to the patient, and overwraps to hold the product to the patient.
根据最新的财务报表(Form-10K),Modular Medical Inc 的总资产为 $0,净损失为 $0
MODD 的关键财务比率是什么?
Modular Medical Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Modular Medical Inc 的收入按细分市场或地理位置如何划分?
Modular Medical Inc 最大收入来源是 Long-term Business,在最近的收益报告中收入为 40,920,000,000。就地区而言, United Kingdom and Ireland 是 Modular Medical Inc 的主要市场,收入为 53,399,000,000。